Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review

Jiao Lin; Li-Min Huang; Jing-Jing Wang; Jian-Hua Mao

首页> 中文期刊> 《世界儿科杂志(英文版)》 >Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review

Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Background Huaiqihuang(HQH)granule is a traditional Chinese herbal complex that has been used as an adjuvant treatment in clinics for the primary nephrotic syndrome(PNS)for many years.However,the effectiveness and safety of HQH have not been systematically discussed.This review aimed to evaluate the effectiveness and safety of HQH in paediatric patients with PNS.Methods The following databases were searched from inception to Mar 2019:MEDLINE,Cochrane Library,EMBASE,CNKI,Wanfang Database,the Chinese Scientific Journal Database and the Chinese biomedical literature service system.All the randomized controlled trials(RCTs)eligible for inclusion were included.The primary outcomes were relapse,infection,remission and adverse events.The secondary outcomes included serum immunoglobulin levels(IgA,IgG or IgM),T-lymphocyte subtype(CD3+,CD4+,CD8+,CD4+/CD8+),IL-10,TNF-α,TNF-γ,total cholesterol and time of proteinuria turning negative.Results Fourteen RCTs(885 patients)were identified.Treatment with HQH reduced the chance of relapse[relative risk(RR):0.47;95%CI:0.34,0.66;P<0.001]and infections(RR:0.47;95%Cl:0.35,0.62;P<0.001).No significant difference was found in adverse events.HQH also increased the serum levels of IgA[weighted mean difference(WMD):0.40;95%Cl:0.20,0.60;P<0.001]and IgG(WMD:1.58;95%Cl:1.38-1.78;P<0.001),as well as CD4+[standard mean difference(SMD):0.90;95%Cl:0.12-1.68;P=0.02],CD3+(WMD:4.04;95% CI:3.27-4.82;P<0.001),and the CD4^(+)/CD8^(+)ratio(WMD:0.31;95% CI:0.21-0.41;P<0.001),but decreased the level of CD8+cells(WMD:-3.39;95% CI:-5.73-1.05;P=0.004).No statistically significant difference was found in IgM(WMD:0.05;95% CI:-0.13,0.24;P=0.57).Conclusions HQH could reduce the rate of relapse and the frequency of infection in children with PNS.No apparent adverse effects were found.Moreover,the beneficial influence of HQH may act through immunomodulation.Additional multi-center,large-sample,high-quality studies are needed to confirm the effectiveness and safety of HQH.

著录项

来源
《世界儿科杂志(英文版)》 |2021年第3期|P.242-252|共11页
作者
Jiao Lin; Li-Min Huang; Jing-Jing Wang; Jian-Hua Mao;
展开▼
作者单位

Department of Nephrology National Clinical Research Center For Child Health Children’s Hospital Zhejiang University School of Medicine Hangzhou 310003 China;

Department of Nephrology National Clinical Research Center For Child Health Children’s Hospital Zhejiang University School of Medicine Hangzhou 310003 China;

Department of Nephrology National Clinical Research Center For Child Health Children’s Hospital Zhejiang University School of Medicine Hangzhou 310003 China;

Department of Nephrology National Clinical Research Center For Child Health Children’s Hospital Zhejiang University School of Medicine Hangzhou 310003 China;

展开▼
原文格式 PDF
正文语种 chi
中图分类肿瘤学;
关键词
Children Huaiqihuang; Nephrotic syndrome; Meta-analysis;

Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review

摘要

著录项

相关主题

期刊订阅